James McMahon – Kerrang! Editor from 2011 to 2017 – has died aged 44 from soft tissue sarcoma.

Immutep (IMMP) has released an update. Immutep Limited has announced promising results from its Phase II trial of eftilagimod alpha, combined ...

Tributes are being paid to former Kerrang! editor, music journalist and podcaster James McMahon, who passed away aged 44 on ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

News of his death was shared by former NME editor Conor McNicholas, who wrote: “James was someone who really mattered – his words mattered. His actions mattered. He connected people in new ways and ...

Fans of Cape cuisine are in for a treat as Gadija Sydow makes her triumphant return to the screen with her new cooking series ...

First patient dosed in randomized, Phase 2 study in presurgical triple negative breast cancer SHELTON, Conn., Nov. 13, 2024 /PRNewswire/ -- Intensity Therapeutics ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

If I only have around three years left to live, what's the point in A-levels?" According to bone and soft tissue cancer ...

Reese McHenry was often described as a force of nature. After growing up in northern Minnesota and western Wisconsin, she ...

Just as the fledgling establishment carved its niche in the community, it was forced to shutter when Fraser was diagnosed ...